A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis-Reference-Cited by-同舟云学术

A Bivalent Anthrax–Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis

Published:2017-06-26 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Tao Pan,Mahalingam Marthandan,Zhu Jingen,Moayeri Mahtab,Kirtley Michelle L.,Fitts Eric C.,Andersson Jourdan A.,Lawrence William S.,Leppla Stephen H.,Chopra Ashok K.,Rao Venigalla B.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Preventing the use of biological weapons: improving response should prevention fail;Inglesby;Clin Infect Dis,2000

2. Facing the biological weapons threat;O’Toole;Lancet,2000

3. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense;Inglesby;JAMA,2000

4. Anthrax as a biological weapon, 2002: updated recommendations for management;Inglesby;JAMA,2002

5. Anthrax pathogenesis;Moayeri;Annu Rev Microbiol,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant bacteriophage T4 displaying key epitopes of the foot-and-mouth disease virus as a novel nanoparticle vaccine;International Journal of Biological Macromolecules;2024-02

2. Animal Models for Infectious Disease Vaccine Development;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

3. T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines;Antiviral Research;2023-09

4. Rapid Development of a Mucosal Nanoparticle Flu Vaccine by Genetic Engineering of Bacteriophage T4 using CRISPR-Cas;2022-06-14

5. Vaccines Against Anthrax – Selected Research;Postępy Mikrobiologii - Advancements of Microbiology;2022-03-01